share_log

乐普生物-B与乐普医疗订立CDMO服务框架协议

Lepu Bio-B and Lepu Healthcare enter into CDMO service framework agreement

新浪港股 ·  Nov 13, 2023 19:49

Lepu Bio-B (02157) announced that on November 13, 2023, the company entered into a CDMO service framework agreement with Lepu Healthcare. The company and/or its subsidiaries agreed to provide CDMO technical services to Lepu Medical and/or its subsidiaries.

The Group is mainly engaged in the research and development of its drug candidates and operates a bioreactor production line that complies with GMP standards. The production line has been in operation since the end of 2019.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment